AUSTRALIAN PRODUCT RECALL

Dasatinib Dr. Reddy's dasatinib 50 mg film coated tablet blister pack and Dasatinib Dr. Reddy's dasatinib 100 mg film coated tablet blister pack

Published 14 October 2022

Product

Dasatinib Dr. Reddy's dasatinib 50 mg film coated tablet blister pack Batch No. ZH20021 (50mg); Product Code: 36456 Expiry date: 06/2023 Dasatinib Dr. Reddy's dasatinib 100 mg film coated tablet blister pack Batch No. ZH20023 (100mg); Product Code: 36458 Expiry date: 12/2023 ARTG 337451 (Dasatinib Dr. Reddy's dasatinib 50 mg film coated tablet blister pack) ARTG 337460 (Dasatinib Dr. Reddy's dasatinib 100 mg film coated tablet blister pack) Prescription only medicine for for the treatment of chronic myeloid leukaemia (CML). It is also used to treat a particular form of acute lymphoblastic leukaemia (ALL) called Philadelphia chromosome positive or Ph+ ALL. 

Why it was recalled

The tablet may not dissolve properly and this can result in incomplete release of the medicine.

Hazard

If patients receive a lower dose of the medicine than prescribed, the medicine may be less effective, increasing the risk of serious adverse health effects.

Read the official notice ↗

Source: Product Safety Australia. RecallMatch AU provides a screening summary and is independent of the ACCC.